Beyond the nervous system, GLP-1 signaling intersects with immune regulation
Not everyone needs this highest dose
All FDA-approved GLP-1 medications have demonstrated improved fasting blood glucose and HbA1c reductions compared to placebo
Semaglutide, a medication used to treat type 2 diabetes, increased the likelihood of improvement in non-alcoholic steatohepatitis (NASH) without worsening liver fibrosis, according to research presented at the AASLD virtual Liver Meeting
Pharmacy Variation: Prices can differ between pharmacies in Beverly Hills and Las Vegas, affecting overall expenses
Theres also this recent headline: Which is a touchy subject and I dont want to settle the European regulators investigation (notoriously not overly sensitive about things), but Id venture to say that the psychological impact of obesity and the psychiatric side effects associated with changing body type including dysmorphia and eating disorders probably indicate that this is not a side effect of the drug but rather a side effect of the primary effect of the drug, in a small subset of patients